Department of Chemistry Organic Chemistry 3 Bielefeld University Bielefeld Germany

Institute of Microbiology of the Czech Academy of Sciences v v i Prague Czechia

The Bartholin Institute Department of Pathology Rigshospitalet Copenhagen Denmark

Translational Type 1 Diabetes Research Clinical Research Steno Diabetes Center Copenhagen Herlev Denmark

Editorial on the Research Topic The gut-pancreas axis in type 1 diabetes – a focus on environmental factors PubMed

Zobrazit více v PubMed

Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet (2004) 364:1699–700. doi:  10.1016/S0140-6736(04)17357-1 PubMed DOI

Neuman V, Pruhova S, Kulich M, Kolouskova S, Vosahlo J, Romanova M, et al. Gluten-free diet in children with recent-onset type 1 diabetes: A 12-month intervention trial. Diabetes Obes Metab (2020) 22:866–72. doi:  10.1111/dom.13974 PubMed DOI

Carre A, Vecchio F, Flodstrom-Tullberg M, You S, Mallone R. Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention. Endocr Rev (2023) 44:737–51. doi:  10.1210/endrev/bnad007 PubMed DOI

Bruun SW, Josefsen K, Tanassi JT, Marek A, Pedersen MH, Sidenius U, et al. Large gliadin peptides detected in the pancreas of NOD and healthy mice following oral administration. J Diabetes Res (2016) 2016:2424306. doi:  10.1155/2016/2424306 PubMed DOI PMC

Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia (2006) 49:2824–7. doi:  10.1007/s00125-006-0465-3 PubMed DOI

Hanninen A, Toivonen R, Poysti S, Belzer C, Plovier H, Ouwerkerk JP, et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut (2018) 67:1445–53. doi:  10.1136/gutjnl-2017-314508 PubMed DOI

Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev (1999) 15:323–7. doi:  10.1002/(sici)1520-7560(199909/10)15:5<323::aid-dmrr53>3.0.co;2-p PubMed DOI

Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab (2003) 88:162–5. doi:  10.1210/jc.2002-021177 PubMed DOI

Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabetes Stud (2004) 1:39–41. doi:  10.1900/RDS.2004.1.39 PubMed DOI PMC

Svensson J, Sildorf SM, Pipper CB, Kyvsgaard JN, Bojstrup J, Pociot FM, et al. Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study. Springerplus (2016) 5:994. doi:  10.1186/s40064-016-2641-3 PubMed DOI PMC

Abdellatif AM, Sarvetnick NE. Current understanding of the role of gut dysbiosis in type 1 diabetes. J Diabetes (2019) 11:632–44. doi:  10.1111/1753-0407.12915 PubMed DOI

Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun (2018) 9:3294. doi:  10.1038/s41467-018-05470-4 PubMed DOI PMC

Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes (2020) 12:1–24. doi:  10.1080/19490976.2020.1788899 PubMed DOI PMC

Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology (2011) 141:237–248, 248 e231. doi:  10.1053/j.gastro.2011.04.007 PubMed DOI

Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, et al. Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia (2022) 65:2108–20. doi:  10.1007/s00125-022-05779-2 PubMed DOI PMC

Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes (2015) 64:1682–7. doi:  10.2337/db14-1370 PubMed DOI

Pozzilli P, Bosi E, Cirkel D, Harris J, Leech N, Tinahones FJ, et al. Randomized 52-week phase 2 trial of albiglutide versus placebo in adult patients with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab (2020) 105:e2192–e2206. doi:  10.1210/clinem/dgaa149 PubMed DOI

Herold KC, Reynolds J, Dziura J, Baidal D, Gaglia J, Gitelman SE, et al. Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diabetes Obes Metab (2020) 22:2045–54. doi:  10.1111/dom.14121 PubMed DOI PMC

Edwards K, Li X, Lingvay I. Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study. J Clin Endocrinol Metab (2023) 108:920–30. doi:  10.1210/clinem/dgac618 PubMed DOI

McLeod KH, Mason L, Marino E. Transplantation of fecal microbiota shaped by diet. Bio Protoc (2018) 8:e2683. doi:  10.21769/BioProtoc.2683 PubMed DOI PMC

Funsten MC, Yurkovetskiy LA, Kuznetsov A, Reiman D, Hansen CHF, Senter KI, et al. Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetes. Cell Host Microbe (2023) 31:213–227 e219. doi:  10.1016/j.chom.2022.12.009 PubMed DOI PMC

Tlaskalova-Hogenova H, Stepankova R, Tuckova L, Farre MA, Funda DP, Verdu EF, et al. Autoimmunity, immunodeficiency and mucosal infections: chronic intestinal inflammation as a sensitive indicator of immunoregulatory defects in response to normal luminal microflora. Folia Microbiol (Praha) (1998) 43:545–50. doi:  10.1007/BF02820817 PubMed DOI